2025-01-16FDA approves acalabrutinib with bendamustine and rituximab for previously untreated mantle cell lymphomaDrugs Calquence (acalabrutinib) · BTK inhibitor, bendamustine · Nitrogen mustard, rituximab · Anti-CD20 antibodyConditionLymphoid
2019-06-10FDA approves polatuzumab vedotin-piiq for diffuse large B-cell lymphomaDrugs POLIVY (polatuzumab vedotin-piiq) · Anti-CD79B antibody-drug conjugate, bendamustine · Nitrogen mustard, rituximab · Anti-CD20 antibodyConditionLymphoid
2006-02-10FDA approves rituximab (Rituxan) for use in the first‑line treatment of patients with diffuse large B-cell, CD20‑positive, non-Hodgkin's lymphoma in combination with CHOP or other anthracycline‑based chemotherapy regimensDrugs Rituxan (rituximab) · Anti-CD20 antibody, cyclophosphamide · Nitrogen mustardConditionLymphoid